Trial record 1 of 1 for: NCT03248531
Previous Study | Return to List | Next Study
A Study to Test the Efficacy, Safety and Pharmacokinetics of Bimekizumab in Subjects With Moderate to Severe Hidradenitis Suppurativa.
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03248531|
Recruitment Status : Completed
First Posted : August 14, 2017
Last Update Posted : March 20, 2020
UCB Biopharma S.P.R.L.
Information provided by (Responsible Party):
UCB Pharma ( UCB Biopharma S.P.R.L. )
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Completed|
|Actual Primary Completion Date :||November 23, 2018|
|Actual Study Completion Date :||February 21, 2019|
|Certification/Extension First Submitted :||November 22, 2019|